Episode 106
Microdosing GLP-1 and Cagrisema headlines
Drs. Karl and Spencer discuss the concept of "microdosing" GLP-1 receptor agonists along with talk about the new topline results from REDEFINE which studied the new drug CagriSema.
December 23, 202440m 20sExplicit
Audio is streamed directly from the publisher (injector.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Drs. Karl and Spencer discuss the concept of "microdosing" GLP-1 receptor agonists along with talk about the new top line results from REDEFINE which studied the new drug CagriSema.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.